Zephyrnet Logo

Generative Data Intelligence

Tag: Novartis

Some Concerns about the Amendment Process to Key Patent Levers: A “Captured” Patent Office?

Patents
In light of the recent Patent (Amendment) Rules, 2024, we are pleased to bring this post by Prashant Reddy T., which was written in...

Top News

Journey Through “Decembers” on SpicyIP (2005 – Present)

Patents
2023 has become yesteryear. 2024 has arrived. (Hope you all had a wonderful year beginning!). January is bidding adios now. In short, I am...

Delhi High Court Clarifies that Opposition and Examination Run on Parallel Tracks 

Patents
In Novartis AG v. NATCO, the DB of DHC had to determine the “extent of engagement of pre-grant opposition in the course of proceedings initiated by...

Intellectual Property as a Catalyst: Promoting Inclusiveness, Empowerment, and Development

Patents
INTRODUCTION “The future of the nation depends in no small part on the efficiency of industry, and the efficiency of the industry depends in no...

SpicyIP Weekly Review (January 8-January 14)

Patents
Here is a brief recap of IP developments from last week. Do read our summaries of the post about a party seeking help from...

Alphabet’s Isomorphic Secures Lucrative Pharma Deals Worth Nearly $3 Billion

AI
In a strategic move within Alphabet, Isomorphic, the brainchild of Google DeepMind, has successfully sealed two substantial pharmaceutical agreements with industry giants Eli Lilly...

Alnylam Announces Preliminary* Fourth Quarter and Full Year 2023 Global Net Product Revenues and Provides Additional Updates

Fintech
– Achieved Full Year 2023 Preliminary Global Net Product Revenues of $1,241 Million for ONPATTRO®, AMVUTTRA®, GIVLAARI®, and OXLUMO®, Representing 39% Annual Growth (39%...

2023 IPR NOTEWORTHY JUDGEMENTS AND DEVELOPMENTS- THE IP PRESS

Patents
Greetings from The IP Press! We wish you a very Happy 2024! This compilation contains the compilation of significant judgments of 2023 which are related to...

A Look Back at India’s Top IP Developments of 2023

Patents
.  As 2023 comes to an end, in line with our annual tradition, we take stock of the top IP developments that occurred this year....

SpicyIP Weekly Review (December 18- December 24)

Patents
From an in-depth discussion on the terms of copyright and translations in India to the recent UK Supreme Court’s order regarding the patentability of...

Freenome launches lung cancer trial ahead of FDA approval bid

Medical Devices

Boehringer Ingelheim signs up with IBM for AI therapy

AI
Boehringer Ingelheim is the latest pharma company to turn to AI in the hunt for new treatments and therapies. The German company announced earlier this...

Drugmakers Argue Double Patenting Ruling Defies Congress – Law360

Patents
By Dani Kass (November 28, 2023, 9:58 PM EST) -- AbbVie, Merck, Johnson & Johnson, AstraZeneca, Novartis and other big-name pharmaceutical companies are...
123...16Page 1 of 16

Latest Intelligence

spot_img
spot_img

Copyright @ 2024 Plato Technologies Inc.